Publication:
Plasma gastrin levels during oral glucose tolerance test and insulin tolerance test in acromegaly

dc.contributor.authorDjuric, D.S. (7005070108)
dc.contributor.authorPopovic, V. (35451450900)
dc.contributor.authorMicic, D. (7006038410)
dc.contributor.authorNesovic, M. (7004028634)
dc.date.accessioned2025-07-02T13:00:41Z
dc.date.available2025-07-02T13:00:41Z
dc.date.issued1984
dc.description.abstractThis study has shown that there were not any significant increments (during ITT) or decrements (during OGTT) of plasma gastrin values in patients with acromegaly. Neither did gastrin response to ITT or OGTT differ in patients who had hyperprolactinaemia also. There is experimental evidence for increased concentration of gastrin in blood following insulin injection and for reduced concentration in the presence of hyperglycaemia. The release of gastrin depends both on the degree of hypoglycaemia achieved and the adrenergic response provoked as shown by Frier, Cirall, Adrian and Bloom (1982). There is no clear evidence however that these agents are involved in the physiological control of gastrin release (Blair, Grund, Kay, Lund, Reed, Sanders, Thompson and Venables 1978). The fact that gastrin circulates in a number of different molecular forms with different biological potencies further complicates the interpretation.
dc.identifier.urihttps://doi.org/10.1055/s-2007-1014709
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0021349087&doi=10.1055%2fs-2007-1014709&partnerID=40&md5=28647d95cbc759ec732e81c27222eb49
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/14726
dc.titlePlasma gastrin levels during oral glucose tolerance test and insulin tolerance test in acromegaly
dspace.entity.typePublication

Files